Nuplazid is the first and only FDA-approved therapy proven to control hallucinations and delusions without impacting motor function for patients with Parkinson's Disease Psychosis. The creative team represented the disease state as "chaos" with a lot of elements on the brain. With the treatment, the brain will go from "chaos" to "calm". We also used arrows in our art work to show the progressive treatment.

  • Client ACADIA Pharmaceuticals